We Can Medicines Co., Ltd. (TPEX:6929)

Chimerix Statistics

Total Valuation

TPEX:6929 has a market cap or net worth of TWD 1.44 billion. The enterprise value is 2.46 billion.

Market Cap	1.44B
Enterprise Value	2.46B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6929 has 44.99 million shares outstanding. The number of shares has increased by 5.31% in one year.

Current Share Class	44.99M
Shares Outstanding	44.99M
Shares Change (YoY)	+5.31%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	1.17%
Float	5.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.44
PB Ratio	1.30
P/TBV Ratio	1.30
P/FCF Ratio	7.25
P/OCF Ratio	5.83
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.24, with an EV/FCF ratio of 12.44.

EV / Earnings	-34.95
EV / Sales	0.76
EV / EBITDA	10.24
EV / EBIT	n/a
EV / FCF	12.44

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 1.17.

Current Ratio	1.61
Quick Ratio	0.58
Debt / Equity	1.17
Debt / EBITDA	5.37
Debt / FCF	6.52
Interest Coverage	-2.79

Financial Efficiency

Return on equity (ROE) is -6.19% and return on invested capital (ROIC) is -1.83%.

Return on Equity (ROE)	-6.19%
Return on Assets (ROA)	-1.44%
Return on Invested Capital (ROIC)	-1.83%
Return on Capital Employed (ROCE)	-3.34%
Revenue Per Employee	3.23M
Profits Per Employee	-70,058
Employee Count	1,005
Asset Turnover	1.02
Inventory Turnover	2.60

Taxes

Income Tax	-4.29M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.52% in the last 52 weeks. The beta is -0.43, so TPEX:6929's price volatility has been lower than the market average.

Beta (5Y)	-0.43
52-Week Price Change	-51.52%
50-Day Moving Average	33.66
200-Day Moving Average	38.17
Relative Strength Index (RSI)	37.63
Average Volume (20 Days)	5,744

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6929 had revenue of TWD 3.25 billion and -70.41 million in losses. Loss per share was -1.58.

Revenue	3.25B
Gross Profit	1.07B
Operating Income	-73.09M
Pretax Income	-74.70M
Net Income	-70.41M
EBITDA	-4.00M
EBIT	-73.09M
Loss Per Share	-1.58

Balance Sheet

The company has 264.13 million in cash and 1.29 billion in debt, giving a net cash position of -1.03 billion or -22.81 per share.

Cash & Cash Equivalents	264.13M
Total Debt	1.29B
Net Cash	-1.03B
Net Cash Per Share	-22.81
Equity (Book Value)	1.11B
Book Value Per Share	24.60
Working Capital	530.23M

Cash Flow

In the last 12 months, operating cash flow was 246.16 million and capital expenditures -48.34 million, giving a free cash flow of 197.82 million.

Operating Cash Flow	246.16M
Capital Expenditures	-48.34M
Free Cash Flow	197.82M
FCF Per Share	4.40

Margins

Gross margin is 32.95%, with operating and profit margins of -2.25% and -2.17%.

Gross Margin	32.95%
Operating Margin	-2.25%
Pretax Margin	-2.30%
Profit Margin	-2.17%
EBITDA Margin	-0.12%
EBIT Margin	-2.25%
FCF Margin	6.09%

Dividends & Yields

TPEX:6929 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-5.31%
Shareholder Yield	n/a
Earnings Yield	-4.91%
FCF Yield	13.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6929 has an Altman Z-Score of 1.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.92
Piotroski F-Score	4